Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Cancer
>
2015
>
34
>
7
Volume:
34
Issue:
7
1. Global efforts in conquering lung cancer in China.
Page:320—322
2. Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what's new and what's enough.
Page:310—319
3. Insight into early-phase trials for lung cancer in the United States.
Page:288—294
4. Early-Phase Oncology Research Training (EFFORT) program: a Hengrui-USCACA joint scholarship.
Page:323—324
5. Parallel phase 1 clinical trials in the US and in China: accelerating the test of avitinib in lung cancer as a novel inhibitor selectively targeting mutated EGFR and overcoming T790M-induced resistance.
Page:285—287
6. Predictive biomarkers in precision medicine and drug development against lung cancer.
Page:295—309